Germany · Delayed Price · Currency is EUR Intra-Cellular Therapies Statistics
Total Valuation
FRA:OSB has a market cap or net worth of EUR 647.39 million.
| Market Cap | 647.39M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Wednesday, July 16, 2025.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | Jul 25, 2025 |
Share Statistics
| Current Share Class | 45.06M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.48% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 42.98M |
Valuation Ratios
The trailing PE ratio is 9.08 and the forward PE ratio is 6.82.
| PE Ratio | 9.08 |
| Forward PE | 6.82 |
| PS Ratio | 2.69 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.51%.
| Return on Equity (ROE) | 12.51% |
| Return on Assets (ROA) | 1.47% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 273,973 |
| Profits Per Employee | 81,279 |
| Employee Count | 877 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:OSB has paid 22.92 million in taxes.
| Income Tax | 22.92M |
| Effective Tax Rate | 24.33% |
Stock Price Statistics
The stock price has decreased by -1.94% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -1.94% |
| 50-Day Moving Average | 15.09 |
| 200-Day Moving Average | 15.33 |
| Relative Strength Index (RSI) | 40.28 |
| Average Volume (20 Days) | 42 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.75 |
Income Statement
In the last 12 months, FRA:OSB had revenue of EUR 240.27 million and earned 71.28 million in profits. Earnings per share was 1.56.
| Revenue | 240.27M |
| Gross Profit | 240.27M |
| Operating Income | 102.75M |
| Pretax Income | 94.21M |
| Net Income | 71.28M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 1.56 |
Balance Sheet
The company has 120.71 million in cash and 112.85 million in debt, giving a net cash position of 7.86 million.
| Cash & Cash Equivalents | 120.71M |
| Total Debt | 112.85M |
| Net Cash | 7.86M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 611.93M |
| Book Value Per Share | 13.58 |
| Working Capital | -4.00B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 42.76% |
| Pretax Margin | 39.21% |
| Profit Margin | 29.67% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.46%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 1.46% |
| Dividend Growth (YoY) | 47.59% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.48% |
| Shareholder Yield | 0.98% |
| Earnings Yield | 11.01% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |